Perspectives of bilateral thoracic sympathectomy for treatment of heart failure
Carregando...
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Autores
Citação
CLINICS, v.76, article ID e3248, 6p, 2021
Resumo
Surgical neuromodulation therapies are still considered a last resort when standard therapies have failed for patients with progressive heart failure (HF). Although a number of experimental studies have provided robust evidence of its effectiveness, the lack of strong clinical evidence discourages practitioners. Thoracic unilateral sympathectomy has been extensively studied and has failed to show significant clinical improvement in HF patients. Most recently, bilateral sympathectomy effect was associated with a high degree of success in HF models, opening the perspective to be investigated in randomized controlled clinical trials. In addition, a series of clinical trials showed that bilateral sympathectomy was associated with a decreased risk of sudden death, which is an important outcome in patients with HF. These aspects indicates that bilateral sympathectomy could be an important alternative in the treatment of HF wherein pharmacological treatment barely reaches the target dose.
Palavras-chave
Heart Failure, Sympathectomy, Myocardial Infarction, Dilated Cardiomyopathy, Pulmonary Hypertension
Referências
- Ajijola OA, 2012, J AM COLL CARDIOL, V59, P91, DOI 10.1016/j.jacc.2011.09.043
- Berliner D, 2018, HERZ, V43, P383, DOI 10.1007/s00059-018-4712-4
- Bertero E, 2018, NAT REV CARDIOL, V15, P457, DOI 10.1038/s41569-018-0044-6
- Booth LC, 2015, HYPERTENSION, V65, P393, DOI 10.1161/HYPERTENSIONAHA.114.04176
- BRISTOW MR, 1982, NEW ENGL J MED, V307, P205, DOI 10.1056/NEJM198207223070401
- Chen SL, 2013, J AM COLL CARDIOL, V62, P1092, DOI 10.1016/j.jacc.2013.05.075
- Colucci WS, 1998, CLIN CARDIOL, V21, P20, DOI 10.1002/clc.4960211305
- Conceicao-Souza GE, 2012, EUR J HEART FAIL, V14, P1366, DOI 10.1093/eurjhf/hfs132
- Silva RDCE, 2020, J THORAC CARDIOV SUR, V160, pE135, DOI 10.1016/j.jtcvs.2019.09.031
- Davies JE, 2013, INT J CARDIOL, V162, P189, DOI 10.1016/j.ijcard.2012.09.019
- Dendorfer A, 2002, HYPERTENSION, V40, P348, DOI 10.1161/01.HYP.0000028001.65341.AA
- Dorn GW, 2009, CARDIOVASC RES, V81, P465, DOI 10.1093/cvr/cvn243
- Florea VG, 2014, CIRC RES, V114, P1815, DOI 10.1161/CIRCRESAHA.114.302589
- FREEDMAN MD, 1991, J CLIN PHARMACOL, V31, P1061, DOI 10.1002/j.1552-4604.1991.tb03673.x
- Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317
- GLOWER DD, 1985, CIRCULATION, V71, P994, DOI 10.1161/01.CIR.71.5.994
- Gold MR, 2016, J AM COLL CARDIOL, V68, P149, DOI 10.1016/j.jacc.2016.03.525
- Greene SJ, 2018, J AM COLL CARDIOL, V72, P351, DOI 10.1016/j.jacc.2018.04.070
- Guo WY, 2012, ACTA CARDIOL, V67, P533, DOI 10.1080/AC.67.5.2174127
- Hamann JJ, 2013, EUR J HEART FAIL, V15, P1319, DOI 10.1093/eurjhf/hft118
- Hu JL, 2014, INT J CARDIOL, V172, pE414, DOI 10.1016/j.ijcard.2013.12.254
- Jonnesco T., 1921, PRESSE MED, V20, P221
- Jordao MR, 2021, CLINICS, V76, DOI 10.6061/clinics/2021/e1958
- KAYE DM, 1994, J AM COLL CARDIOL, V23, P570, DOI 10.1016/0735-1097(94)90738-2
- Krishnan A, 2018, ANN THORAC SURG, V105, pE51, DOI 10.1016/j.athoracsur.2017.09.023
- Lefkowitz RJ, 2000, CIRCULATION, V101, P1634
- Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA
- Liu RX, 2017, INT J BIOCHEM CELL B, V88, P100, DOI 10.1016/j.biocel.2017.05.001
- Madamanchi Aasakiran, 2007, Mcgill J Med, V10, P99
- McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077
- MEREDITH IT, 1993, CIRCULATION, V88, P136, DOI 10.1161/01.CIR.88.1.136
- Miller WL, 2013, JACC-HEART FAIL, V1, P290, DOI 10.1016/j.jchf.2013.05.001
- Miller WL, 2011, JACC-CARDIOVASC IMAG, V4, P946, DOI 10.1016/j.jcmg.2011.06.017
- Morrell NW., 2013, J AM COLL CARDIOL, V62, pD4, DOI [DOI 10.1016/j.jacc.2013.10.025, 10.1016/j.jacc.2013.10.025]
- Packer M, 2015, CIRCULATION, V131, P54, DOI 10.1161/CIRCULATIONAHA.114.013748
- Pego-Fernandes PM, 2010, ARQ BRAS CARDIOL, V95, P685, DOI 10.1590/S0066-782X2010005000152
- Pick JM, 2017, CARDIOL YOUNG, V27, pS126, DOI 10.1017/S1047951116002365
- Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128
- Prins KW, 2016, CARDIOL CLIN, V34, P363, DOI 10.1016/j.ccl.2016.04.001
- Sabbah HN, 2011, HEART FAIL REV, V16, P171, DOI 10.1007/s10741-010-9209-z
- Saku K, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12136
- Schwartz PJ, 2014, NAT REV CARDIOL, V11, P346, DOI 10.1038/nrcardio.2014.19
- Tanai E, 2016, COMPR PHYSIOL, V6, P187, DOI 10.1002/cphy.c140055
- Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555
- Urata H, 1998, HEART FAIL REV, V3, P119, DOI [10.1023/A:10097, DOI 10.1023/A:10097]
- van Empel VPM, 2005, CARDIOVASC RES, V67, P21, DOI 10.1016/j.cardiores.2005.04.012
- Vasconcelos Cesar F M, 2020, Rev Col Bras Cir, V47, pe20202398, DOI 10.1590/0100-6991e-20202398
- Vaseghi M, 2014, HEART RHYTHM, V11, P360, DOI 10.1016/j.hrthm.2013.11.028
- Ventura-Clapier R, 2011, BBA-MOL CELL RES, V1813, P1360, DOI 10.1016/j.bbamcr.2010.09.006
- Wu TJ, 1998, J AM COLL CARDIOL, V32, P187, DOI 10.1016/S0735-1097(98)00184-3
- Zannad F, 2015, EUR HEART J, V36, P425, DOI 10.1093/eurheartj/ehu345
- Zanoni FL, 2017, J THORAC CARDIOV SUR, V153, P855, DOI 10.1016/j.jtcvs.2016.11.037
- Zheng H, 2016, AM J PHYSIOL-HEART C, V311, pH337, DOI 10.1152/ajpheart.00999.2015
- Zhong L, 2012, COMPUT METHOD BIOMEC, V15, P1015, DOI 10.1080/10255842.2011.569885
- Zhou L, 2015, JACC-CARDIOVASC INTE, V8, P2013, DOI 10.1016/j.jcin.2015.09.015
- Zimmer A, 2020, MOL CELL BIOCHEM, V464, P93, DOI 10.1007/s11010-019-03652-2